New Scientific Publication on Outcome Measurement Instruments in Atopic Dermatitis
2021-10-19
Did you know that we are always acquiring new knowledge to help serve our trial studies better through our multiple internal research programs?
We are so excited to share that our very own Dr. Robert Bissonnette, Stephanie Légaré, Ana Palijan and Kevin Kojok, on behalf of @Innovaderm Research Inc, performed a systematic review and meta-analysis looking at the sensitivity of outcome measure instruments (OMIs).
We were able to show that continuous OMIs are more sensitive at detecting treatment effect when compared to dichotomous OMIs in topical clinical trials for atopic dermatitis, hence highlighting their use in proof-of-concept (POC) trials.
Click here to read this innovative article, published to Journal of the European Academy of Dermatology and Venereology: https://onlinelibrary.wiley.com/doi/abs/10.1111/jdv.17743
Newsletter
